Alzheimer's drug benefits 'too small' to offer on NHS, NICE finds
By Lee Peart 19 June 2025
The benefits from Alzheimer’s drugs donanemab and lecanemab are too small to justify the additional costs to the NHS, NICE has found.
Disabled Children's Team Social Worker
£38,220 - £42,839 per annum pro rata
Scarborough, North Yorkshire£38,220 - £42,839 per annum pro rata
Corporate Director Children and Young People’s Service
£141,233 to £164,272 plus relocation support
Northallerton, North Yorkshire£141,233 to £164,272 plus relocation support
Head of Family Support and Child Protection
£88,047 - £107,819
Brent, London (Greater)£88,047 - £107,819
Most Read News
- Streeting vows not to let drug companies 'rip off' UK taxpayers
- Pathology staff across London to strike over pay and grading
- Official investigation into corridor care unveiled
- East of England Ambulance Service faces strike action
- Over half of independent pharmacies could close in next year without further support
Disabled Children's Team Social Worker
£38,220 - £42,839 per annum pro rata
Scarborough, North Yorkshire£38,220 - £42,839 per annum pro rata
Corporate Director Children and Young People’s Service
£141,233 to £164,272 plus relocation support
Northallerton, North Yorkshire£141,233 to £164,272 plus relocation support
Head of Family Support and Child Protection
£88,047 - £107,819
Brent, London (Greater)£88,047 - £107,819
Most Read News
- Streeting vows not to let drug companies 'rip off' UK taxpayers
- Pathology staff across London to strike over pay and grading
- Official investigation into corridor care unveiled
- East of England Ambulance Service faces strike action
- Over half of independent pharmacies could close in next year without further support
©2024 Hemming Group Limited. Registered in England and Wales. Registered No: 490200. VAT number GB342 023 408
